Omeron

Quick links to important sections

Omeron

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Omeron

Property Description
Active ingredient Omeprazole (or Omeprazole magnesium)
Form Gastro-resistant capsule or delayed-release tablet
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Suppression of gastric acid secretion
Origin Synthetic compound (substituted benzimidazole)

What is the Medicine Omeron and Its Pharmacological Class?

Omeron is a pharmaceutical preparation containing the active substance Omeprazole, which is universally recognized as the International Nonproprietary Name (INN) for this compound. This highly specific medication is classified as a Proton Pump Inhibitor (PPI), belonging to the group of substituted benzimidazole derivatives. The substance is a synthetic compound that functions as a powerful antisecretory compound. Omeron is a single-component product whose primary function is to suppress the stomach's acid production. The PPI class is characterized by providing sustained control over gastric acidity compared to older antiacid agents.


Omeron Composition, Form, and General Purpose

Omeron contains the active substance Omeprazole and is typically administered via the oral route in specialized dosage forms, most commonly as a gastro-resistant capsule or a delayed-release tablet. The formulation is critical because the active ingredient is inherently acid-labile (easily destroyed by acid). The medication is thus integrated into enteric-coated granules or pellets, a structural design that allows the Omeprazole to bypass the stomach and be absorbed in the small intestine for systemic availability. The general therapeutic purpose of Omeron is the suppression of gastric acid secretion, which provides long-lasting relief from discomfort associated with excessive gastric acidity, a feature that allows the digestive tract to manage corrosive acid exposure effectively.

Regulatory References

  1. Omeprazole (StatPearls/NIH)

What side effects are possible with Omeron?

Possible Side Effects and Safety Information

The official safety profile for Omeprazole (Omeron) details adverse reactions across several physiological systems and classifies their expected frequency based on clinical use data. The profile is organized according to categories consistent with governmental regulatory standards (e.g., FDA and EMA).


Frequency-Classified Adverse Reactions

The most common (geq 1% to < 10%) documented adverse reactions primarily affect the gastrointestinal and nervous systems. These frequently reported effects include headache, abdominal pain, nausea, diarrhea, vomiting, flatulence, and constipation.

Less uncommon effects (geq 0.1% to < 1%) may involve dizziness, insomnia, fatigue, rash, and pruritus. Rare reactions (geq 0.01% to < 0.1%) include hypersensitivity reactions such as angioedema, myalgia, and acute tubulointerstitial nephritis.


Serious Adverse Reactions and Duration-Related Safety

Regulatory documentation lists several serious adverse reactions, although they are typically rare. These include Severe Cutaneous Adverse Reactions (SCARs), Hypomagnesemia (low serum magnesium), and an increased risk of Bone Fracture affecting the hip, wrist, or spine. These serious safety concerns, particularly fracture and hypomagnesemia, are explicitly associated with long-term daily use (e.g., over one year).

Additionally, long-term therapy (over three years) has been noted to increase the risk of Cyanocobalamin (Vitamin B-12) deficiency and the development of Fundic Gland Polyps.

Population-Specific Safety

Safety notes address certain populations. For instance, in pediatric patients (ages 1–16), the profile is similar to adults, but fever and respiratory system events were frequently reported. The label also contains specific considerations for patients with severe hepatic impairment, where increased systemic exposure is noted.

Omeprazole is contraindicated in patients with known hypersensitivity to the active substance or any substituted benzimidazoles.

Overdose and Emergency Response

Overdose and when to seek help

The following information details the officially documented overdose profile for Omeprazole (Omeron) based strictly on governmental regulatory documents.

Feature Official Regulatory Statement
Documented overdose presentations Symptoms reported in overdose cases include gastrointestinal distress (nausea, vomiting, diarrhea, abdominal pain, flatulence), CNS effects (headache, confusion, drowsiness, blurred vision), and autonomic signs (tachycardia, increased sweating, flushing).
Physiological systems affected Central Nervous System (CNS), Cardiovascular system, and Gastrointestinal system.
Dose-related factors Overdoses up to 2,400 mg have been reported.
Severity classification Overdoses have generally not been reported as life-threatening.
Antidote information No specific antidote is known for Omeprazole overdose.

Official Emergency Actions

  • The strict regulatory mandate is to seek emergency medical attention or immediately call a Poison Help line.
  • Urgent medical help is required if the person has collapsed, is having a seizure, has trouble breathing, or cannot be awakened.

Procedural Management

Treatment for overdose is required to be symptomatic and supportive. Regulatory labels note that Omeprazole is extensively bound to plasma protein and is therefore not readily dialyzable. Management focuses on these general supportive measures.

Therapeutic Uses of Omeron

What Omeron treats: main uses and benefits

The therapeutic domain of Omeron (omeprazole) involves providing supportive relief in conditions linked to organ-specific functional stress caused by excessive stomach acid.

Omeprazole is applied in addressing symptom clusters that may become intense or disruptive due to acid reflux. Prescription uses generally include addressing symptoms and supporting resolution of tissue changes associated with gastroesophageal reflux disease (GERD), managing symptoms linked to stomach and duodenal ulcers, and is relevant for easing symptoms associated with pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.

Additionally, it is commonly used in combination with antibiotics for H. pylori eradication and may play a role in managing the risk of ulcer recurrence. In certain contexts, the medication may assist with maintaining functional stability by providing symptomatic relief for frequent heartburn. This support contributes to easing the overall symptom burden and improved comfort during symptomatic periods.

“This is relevant for easing symptoms related to inflammatory or irritative states often caused by gastric acid.”


Quick Fact: Relief for symptoms related to physical discomfort (heartburn, acid reflux, and related systemic imbalance).

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who can and cannot use Omeron?

Eligibility to use Omeron (omeprazole) is strictly governed by regulatory criteria based on specific population characteristics and health status.

Absolute Contraindications

Omeron must not be used by any individual with a documented history of hypersensitivity to the active substance, to any excipients in the formulation, or to any other drug within the substituted benzimidazoles class. Use is also formally prohibited if the patient is taking specific antiretroviral medicines, such as nelfinavir or rilpivirine, due to severe regulatory restrictions.

Age and Organ Function Restrictions

  • Age-Group: The medicine is established for use in adults and in most pediatric patients over one year of age (ge 10 kg) for approved uses. Safety and effectiveness have not been established in infants under one year old.
  • Organ Function: Patients with impaired hepatic function (liver disease) require caution, and official labeling advises considering a dosage reduction. Patients with renal impairment (kidney disease) typically do not require dose adjustment.

Conditional Use

Official documents advise caution for use during pregnancy and note the drug is excreted into milk, necessitating a decision to discontinue the drug or discontinue nursing in breastfeeding mothers. Use is also restricted for individuals with rare hereditary conditions like total lactase deficiency due to formulation excipients.

What should I know about interactions with other medicines?

Omeron (Omeprazole) may interact with a range of medicinal products primarily through two key mechanisms: altering gastric acidity and affecting liver enzymes. Omeron reduces stomach acid, which can decrease the absorption and effectiveness of drugs that require an acidic environment, such as the antifungals Ketoconazole and Itraconazole, as well as some antivirals like Atazanavir and Nelfinavir. For this reason, co-administration with these antiretroviral agents is generally not recommended.

Omeron is also a potent inhibitor of the liver enzyme CYP2C19. This inhibition can lead to increased blood concentrations of drugs metabolized by this pathway, including Diazepam, Phenytoin, and Cilostazol, potentially necessitating a dose reduction of the co-administered medicine. Conversely, this same enzyme inhibition is clinically significant with the antiplatelet drug Clopidogrel, as it prevents the formation of Clopidogrel's active metabolite, thus reducing its intended anti-clotting effect. Concomitant use with Clopidogrel is advised against.

Caution is also warranted with other agents like the blood thinner Warfarin and the immunosuppressant Tacrolimus, as Omeprazole can increase their levels or effects, requiring vigilant monitoring of clinical metrics like INR or drug serum concentrations. The use of Omeprazole with strong enzyme inducers such as Rifampin or the herbal product St John's Wort may reduce Omeprazole's own efficacy, and should be avoided.

Mechanism of Action

How Omeron Works

The action of Omeprazole (Omeron) is defined by its selective and irreversible effect on the final step of acid production within the stomach lining.


️ Irreversible Blockade of the Proton Pump

Omeprazole is a prodrug that is activated only when it localizes in the highly acidic environment of the stomach's parietal cells. Once activated, the compound forms a permanent, covalent bond with the H^+, K^+-ATPase enzyme, or Proton Pump. This mechanism directly and irreversibly inhibits the pump, which is the singular molecular machine responsible for transporting hydrogen ions ( H^+) into the stomach lumen to form hydrochloric acid.


⏳ Prolonged Reduction of Acid Secretion

Due to the irreversible nature of this chemical bond, the cell must synthesize and incorporate entirely new Proton Pumps to restore its ability to produce acid. The physiological result is a profound and long-lasting reduction of gastric acid secretion, regardless of stimulating signals like food or hormones. This effect persists far beyond the time the drug itself is present in the bloodstream, leading to a prolonged elevation of the stomach's pH level.

Dosage and Administration Information

The administration of this medicine (referred to here by its generic component, omeprazole) must strictly follow the instructions detailed in the prescribing information.

Administration and Timing

The medicine is taken orally and is typically prescribed as a once-daily dose. Instructions state that it should be taken before eating, with the dose for most once-daily regimens scheduled for the morning.

Dosage Forms and Preparation

  • Delayed-Release Capsules/Tablets: These must be swallowed whole. They should not be crushed, chewed, or opened, as this compromises the enteric coating necessary for the drug to be released correctly in the body.
  • Delayed-Release Oral Suspension: This form requires specific preparation by mixing the powder packet contents with a precise amount of water, stirring, and consuming the entire mixture within a short, specified timeframe (e.g., 30 minutes) of preparation.

Dosing Schedules and Duration

The required dose and duration of the course are based on the specific condition being addressed. For many standard conditions, a typical adult dose is 20 mg or 40 mg once daily for a short-term course (e.g., 4 to 8 weeks). Conversely, regimens for H. pylori eradication require combination therapy, which often involves a twice-daily dose of 20 mg for 10 to 14 days. Treatment for hypersecretory conditions may require higher initial doses, such as 60 mg once daily, and continue for as long as clinically necessary.

Special Instructions

  • Pediatric Use: The dosage for children (from 1 month to 16 years of age) is determined based on body weight.
  • Missed Dose: If a dose is missed, it should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped to prevent taking two doses at once. Antacids may be used concomitantly.

Recent Clinical Evidence

Research evidence / Overview of studies for Omeron

Evidence from Studies on Gastroesophageal Reflux Disease (GERD) and Esophagitis

Research exploring omeprazole for Gastroesophageal Reflux Disease (GERD) relies heavily on short-term Randomized Controlled Trials (RCTs). These studies were conducted primarily in adults, comparing omeprazole against control agents while measuring changes in symptom intensity and endoscopic healing rates for tissue damage. Studies report on measured changes in symptoms over short treatment intervals. The main uncertainty documented in scientific literature relates to the external validity of early trials and the lack of extensive, long-term comparative RCTs spanning several years.

Evidence from Studies on Peptic Ulcer Healing and Prevention

Omeprazole was studied for ulcer healing using RCTs that monitored ulcer healing rates and measured changes in physical discomfort over short periods. Research also monitored the measured rate of ulcer recurrence in high-risk patients over one year. For the eradication of the H. pylori bacterium, omeprazole is used within combination therapy regimens. Research explored whether these regimens were associated with measured rates of successful bacterial clearance, noting that success rates were observed to relate to factors such as local antibiotic resistance patterns.

Evidence for Rare Pathological Hypersecretory Conditions

Due to the rarity of conditions like Zollinger-Ellison Syndrome (ZES), the evidence relies on long-term observational studies and case series to monitor acid control status. The certainty remains low compared to common indications due to the small sample sizes and non-randomized designs required by these specialized conditions.

Long-term Follow-up and Evidence in Specific Patient Groups

Research has explored the use of omeprazole in pediatric patients (children aged one year and older) and older adults. Findings describe group patterns observed in these studies, but data for certain groups, such as infants younger than one year, remain insufficient and not fully established in well-controlled studies. Long-term effects are not fully established through controlled trials lasting many years, with much of this data coming from observational settings.

Key Studies & References

  1. Omeprazole - StatPearls [Internet] - NCBI Bookshelf (Clinical Overview)
  2. Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS)

Frequently Asked Questions (FAQ)

Common questions about Omeron (FAQ)


Q: How long does it usually take for Omeron to start working?

Official pharmacokinetic data indicates that the medicine's acid-reducing action usually starts within one hour after administration. The full inhibitory effect is typically observed after about four days of repeated daily administration, which is when the medication reaches steady-state acid suppression.


Q: Does Omeron interact with alcohol?

Regulatory documents do not list a direct chemical interaction between Omeprazole and alcohol. However, official information notes that consuming alcohol can stimulate acid production, which may counteract the medication's intended effect on gastric acidity.


Q: Can I drive or operate machinery while on Omeron?

The official product information advises caution. Because the drug's safety profile includes reports of side effects such as dizziness and fatigue, official safety information for the medicine suggests that individuals experiencing these effects should exercise caution or consider avoiding activities that require full alertness.


Q: Is Omeron available without a prescription?

Omeprazole, the active ingredient in Omeron, is available in both prescription and over-the-counter (OTC) forms. The OTC version is specifically intended for the short-term management of frequent heartburn and is typically available in a lower strength with instructions for a limited duration of use on the label.


Q: What are the typical withdrawal symptoms reported for Omeron?

When long-term use of the medication is discontinued, some patients may experience a temporary condition known as rebound acid hypersecretion (RAHS). This is associated with a return or potential worsening of acid-related symptoms, such as heartburn. Regulatory sources suggest that the risk of rebound symptoms is a consideration when discontinuing long-term use.


Q: What is the shelf life of Omeron?

The specific shelf life (expiration date) for the medicine is always printed on the original packaging by the manufacturer. Official storage guidelines generally require the medicine to be kept in a dry place, protected from light and moisture, usually at room temperature (around 20 to 25 C or 68 to 77 F).


Q: Why does Omeron have a 'Black Box' warning?

Official FDA prescribing information states that Omeprazole does not have a 'Black Box' warning. However, regulatory documents do carry important safety warnings about certain drug interactions, most notably the concern regarding the reduced effectiveness of the antiplatelet drug Clopidogrel when taken at the same time.


Q: What is the risk of overdose with Omeron?

According to clinical data, accidental ingestion of doses higher than the maximum recommended amount is generally not expected to cause severe health problems. Reported symptoms of overdose can include nausea, vomiting, a rapid heartbeat, and mild drowsiness. Official guidance emphasizes contacting a healthcare professional or poison control center immediately if an overdose is suspected.


Q: Is Omeron used to treat pain?

Omeron is classified as a Proton Pump Inhibitor, and its primary function is to suppress the production of gastric acid. It is not classified as a general pain reliever (analgesic). The medication is used to address the underlying cause of acid-related conditions, which often results in the relief of associated discomfort.


Q: What happens if I accidentally take two Omeron tablets at once?

Official guidance advises against taking two doses simultaneously. While taking one extra dose is generally considered unlikely to cause serious problems, it does increase the chance of experiencing common side effects like headache or nausea. Individuals who suspect they have taken a dose significantly higher than prescribed are advised to contact a healthcare provider for guidance.


Q: Can Omeron affect the results of a blood test?

Labeling indicates that the medicine may impact certain blood test results, particularly during long-term therapy. For instance, prolonged use has been associated with a decrease in serum magnesium and a risk of Vitamin B-12 deficiency. Additionally, it may increase the levels of a substance called Chromogranin A (CgA), which can potentially interfere with specific diagnostic tests for neuroendocrine tumors.


Q: Do certain foods interfere with how Omeron is absorbed?

Yes, official instructions state that the medicine should be taken before eating, typically in the morning. This timing is specified because food in the stomach may interfere with the way the medication is absorbed, potentially leading to a reduced acid-suppressing effect.


Q: What is the difference between Omeron and its generic version?

Omeron is the brand name for the generic active ingredient Omeprazole. Regulatory standards ensure that both the brand-name and generic versions contain the exact same active chemical. Any differences between them are limited to the inactive ingredients (excipients), as well as variations in packaging and cost.


Q: Why are there different strengths of Omeron available?

According to official regulatory information, various strengths (e.g., 20 mg, 40 mg, 60 mg) are necessary because the required dose is determined by the specific medical condition being addressed. Higher strengths are typically prescribed for treating more severe or complex conditions.


Q: What is the purpose of the filler ingredients in Omeron tablets?

The inactive ingredients, also known as excipients, serve essential technical roles in the formulation. Their primary purpose is to ensure the active ingredient is protected from being destroyed by stomach acid by way of an enteric coating, and to facilitate its proper release and absorption in the small intestine.


Q: Can Omeron be taken with vitamins or supplements?

Official safety documents list that long-term daily use has been linked to a potential deficiency in certain nutrients, including Vitamin B-12 and magnesium. Furthermore, regulatory warnings indicate that co-administration with strong enzyme inducers, such as the herbal product St John's Wort, may reduce the medication's effectiveness.


Q: Are there any common reasons why Omeron might not work for someone?

Official documents acknowledge variability in treatment outcomes due to different factors. For instance, in treating H. pylori, success rates depend on local antibiotic resistance patterns. The drug's metabolism can also vary among patients because its action relies on the liver enzyme CYP2C19, which can differ genetically among individuals.

How should Omeron be stored and disposed of?

Omeron capsules should be stored properly to maintain their efficacy. Keep the medicine in a cool, dry place where the temperature remains below 25°C (77°F). It is essential to protect Omeron from excessive light and moisture. Always keep the capsules in their original packaging until use.

Safe Storage Checklist

Condition Requirement
Temperature Below 25 C
Protection From light and moisture
Security Out of the reach of children and pets

For disposal of expired or unwanted Omeron, do not flush the capsules down a toilet or pour them down a drain unless specifically instructed by a healthcare professional or an authorized disposal list. The preferred method is to utilize a medicine take-back program or permanent disposal site, often available at local pharmacies or community centers. If a take-back program is unavailable, mix the medicine with an unappealing, inedible substance like used coffee grounds or kitty litter, seal it in a plastic bag, and discard it in your household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Omeron found in:

A-Z Index: